Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

13.670
+0.3202.40%
Volume:8.27M
Turnover:113.52M
Market Cap:24.15B
PE:35.97
High:13.990
Open:13.470
Low:13.350
Close:13.350
52wk High:20.620
52wk Low:9.650
Shares:1.77B
HK Float Shares:1.49B
Volume Ratio:1.34
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.380
ROE:10.36%
ROA:3.45%
PB:2.83
PE(LYR):35.97
PS:8.24

Loading ...

Innocare Pharma Issues 2.42 Million New Shares Under 2024 Equity Incentive Plan

Stock News
·
Jun 26

Extensive Orelabrutinib Data Across Regions Might Change The Case For Investing In InnoCare Pharma (SEHK:9969)

Simply Wall St.
·
Jun 22

InnoCare Pharma (SEHK:9969) Stock Could Be 45% Undervalued After EHA 2026 Data

Simply Wall St.
·
Jun 21

Innocare Pharma Shares Surge Over 5% on Positive Phase III Data for Tafasitamab Combo in Frontline DLBCL

Stock News
·
Jun 18

INNOCARE Issues 8 Million Restricted Shares Under Incentive Plan

Stock News
·
Jun 16

InnoCare issues 8.00 million restricted shares (0.45% stake) in first tranche of 2026 RMB Share Incentive Scheme

Bulletin Express
·
Jun 16

InnoCare Pharma: Shareholders Overwhelmingly Approve All 24 Resolutions at 2026 AGM

Bulletin Express
·
Jun 16

Innovative Drug Stocks See Broad Gains as Sector's Outbound Licensing Activity Remains Robust, Supported by Policy Tailwinds and Commercialization Progress

Stock News
·
Jun 12

Innocare Appoints Yuan Bei as Joint Company Secretary

Stock News
·
Jun 05

A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Jun 03

InnoCare Pharma Gets Acceptance for ITP New Drug Application; Shares Up 3%

MT Newswires Live
·
May 29

Innocare's New Drug Application for Orelabrutinib in ITP Accepted for Review by NMPA

Stock News
·
May 28

InnoCare Pharma Wins Australia Approval for Lymphoma Drug

MT Newswires Live
·
May 28

Innocare Pharma's Orelabrutinib Receives Marketing Authorization from Australian TGA

Stock News
·
May 27

InnoCare Pharma to Vest Over 2.4 Million Shares for 74 Employees

MT Newswires Live
·
May 26

Innocare Shares Surge Over 4% in Afternoon Trading Following Milestone in Novel Anti-Inflammatory Drug Trial

Stock News
·
May 21

InnoCare Pharma Unit Doses First Patient in Autoimmune Disease Drug Trial

MT Newswires Live
·
May 13

InnoCare and Zenas BioPharma Dose First Subject in Phase 1 Study of Oral IL-17AA/AF Inhibitor ICP-054

Bulletin Express
·
May 13

Innocare Announces First Patient Dosed in Phase 1 Trial for Oral IL-17 Inhibitor ICP-054 (ZB021)

Stock News
·
May 13

A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Pullback

Simply Wall St.
·
May 11